APA

Buwenge M., Perrone M., Siepe G., Capocaccia I., Woldemariam A. A., Wondemagegnhu T., Uddin K. A. F. M., Sumon M. A., Galofaro E., Macchia G., Deodato F., Cilla S. & Morganti A. G. (2019). Definition of fields margins for the optimized 2D radiotherapy of prostate carcinoma. : Molecular and clinical oncology.

Chicago

Buwenge Milly, Perrone Mariangela, Siepe Giambattista, Capocaccia Ilaria, Woldemariam Aynalem Abraha, Wondemagegnhu Tigeneh, Uddin Kamal A F M, Sumon Mostafa A, Galofaro Elena, Macchia Gabriella, Deodato Francesco, Cilla Savino and Morganti Alessio G. 2019. Definition of fields margins for the optimized 2D radiotherapy of prostate carcinoma. : Molecular and clinical oncology.

Harvard

Buwenge M., Perrone M., Siepe G., Capocaccia I., Woldemariam A. A., Wondemagegnhu T., Uddin K. A. F. M., Sumon M. A., Galofaro E., Macchia G., Deodato F., Cilla S. and Morganti A. G. (2019). Definition of fields margins for the optimized 2D radiotherapy of prostate carcinoma. : Molecular and clinical oncology.

MLA

Buwenge Milly, Perrone Mariangela, Siepe Giambattista, Capocaccia Ilaria, Woldemariam Aynalem Abraha, Wondemagegnhu Tigeneh, Uddin Kamal A F M, Sumon Mostafa A, Galofaro Elena, Macchia Gabriella, Deodato Francesco, Cilla Savino and Morganti Alessio G. Definition of fields margins for the optimized 2D radiotherapy of prostate carcinoma. : Molecular and clinical oncology. 2019.